UniPharma Co., Ltd. (TPEX:6621)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.45
0.00 (0.00%)
Mar 10, 2026, 1:55 PM CST
-28.24%
Market Cap 441.99M
Revenue (ttm) 90.79M
Net Income (ttm) -38.84M
Shares Out 35.50M
EPS (ttm) -1.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 73,737
Average Volume 116,751
Open 12.45
Previous Close 12.45
Day's Range 12.15 - 12.80
52-Week Range 11.40 - 17.80
Beta -0.08
RSI 49.23
Earnings Date May 20, 2026

About UniPharma

UniPharma Co., Ltd. engages in the distribution of pharmaceutical drugs, medical devices, and diagnostic tests in Taiwan. It provides diagnostic tests in areas of oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. The company offers Adept reduction solution; bain, esmolol HCI, and naloxone anesthesia injections; Elisa DR-70 test for in-vitro diagnostics of tumors; and fomeject antidote injection, as well as drug development, research and development, clinical trials, marketing, and other business services. It serves m... [Read more]

Sector Healthcare
Founded 1998
Employees 31
Stock Exchange Taipei Exchange
Ticker Symbol 6621
Full Company Profile

Financial Performance

In 2024, UniPharma's revenue was 93.46 million, a decrease of -9.46% compared to the previous year's 103.22 million. Losses were -24.82 million, 13.8% more than in 2023.

Financial Statements

News

There is no news available yet.